Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT06221046 Not yet recruiting - Clinical trials for Incontinence-associated Dermatitis

Clinical Trial Cream D

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the safety and efficacy of a plant extract incorporated into a standard barrier cream in the treatment of rashes from diarrhea or fecal incontinence.

NCT ID: NCT06220968 Not yet recruiting - Clinical trials for Erectile Dysfunction With Diabetes Mellitus

Impact of Glycemic Control on Penile Duplex Results

Start date: March 2024
Phase:
Study type: Observational [Patient Registry]

The study aimed at evaluating the impact of glycemic control on the erectile function , penile Doppler, and cavernosal blood NO and glutathione levels among a group of diabetic patients with erectile dysfunction.

NCT ID: NCT06220721 Not yet recruiting - Clinical trials for Hypertensive Disorder of Pregnancy

Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia

REPAIR
Start date: July 1, 2024
Phase: Phase 3
Study type: Interventional

The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.

NCT ID: NCT06219707 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome With Constipation

Electro-acupuncture for Irritable Bowel Syndrome With Constipation

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The aim of the clinical trial is to evaluate the efficacy and safety of electro-acupuncture for irritable bowel syndrome with constipation (IBS-C) patients. 60 IBS-C patients will be randomized and allocated to either the electro-acupuncture arm or the sham acupuncture arm.

NCT ID: NCT06219005 Not yet recruiting - Nerve Blocks Clinical Trials

Ultrasound-guided Nerve Block Training Model and Evaluation Method

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to assess emergency medicine physician knowledge and technical skill in performance of ultrasound-guided serratus anterior nerve block in a low-fidelity simulation model workshop and to determine the feasibility, acceptability, and usability of the training program. By performing this study, the investigators hope to create a standardized training model which could potentially facilitate POCUS and critical procedural performance and thereby improve patient care.

NCT ID: NCT06218342 Not yet recruiting - Type 2 Diabetes Clinical Trials

Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease

Start date: February 15, 2024
Phase: Phase 4
Study type: Interventional

This study is a randomized, non-blinded clinical trial specifically designed to assess the initial feasibility and efficacy of SGLT2 inhibitors in treating NAFLD among adults diagnosed with type 2 diabetes.

NCT ID: NCT06218186 Not yet recruiting - Sleep Apnea Clinical Trials

Assessing the Performance of Wesper Lab for Sleep Apnea Diagnosis in Pediatric Populations

Start date: March 2024
Phase: N/A
Study type: Interventional

The goal of this single arm study is to evaluate the effectiveness of Wesper Lab, previously known as TatchSleep Pro, a wireless home sleep test, as a tool to aid in sleep apnea diagnosis as compared to an overnight polysomnography (PSG) evaluation in a pediatric population (subjects 2 to 21 years of age). The main question[s] it aims to answer are: - Does Wesper Lab demonstrate agreement with PSG for the calculation of the apnea/hypopnea index (AHI)? - Does Wesper Lab demonstrate agreement with PFG for the calculation of sleep apnea severity. Participants that are already undergoing a prescribed PSG for the detection of sleep apnea will be asked to simultaneously wear the Wesper Lab sensors and an FDA approved pulse oximeter. Researchers will compare the AHI of Wesper Lab to the AHI of the PSG to determine the accuracy of the Wesper Lab device. This is a single center, single-arm, quantitative study

NCT ID: NCT06217536 Not yet recruiting - Clinical trials for Locally Advanced Soft Tissue Sarcoma

Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas

Start date: July 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multi-center, multi-arm open-label phase Ib/II clinical study assessing the efficacy of concurrent lurbinectedin in combination with radiotherapy in patients with locally advanced, resectable, high-grade sarcomas.

NCT ID: NCT06217419 Not yet recruiting - Asthma Clinical Trials

Proof of Concept of Remote Management of Chronic Inflammatory Airway Diseases for Patient Empowerment

PRECISION
Start date: February 2024
Phase: N/A
Study type: Interventional

Chronic rhinosinusitis (CRS) is a multifactorial disease characterized by persistent symptomatic inflammation of the mucosa of the nose and paranasal sinuses, with (CRSwNP) or without (CRSsNP) the presence of nasal polyps. It affects 5 to 12% of the general population. CRS is often associated with asthma, which has a prevalence of 4% in the general population, reaching 30%-70% among patients with CRS. The current standard clinical evaluation of patients for both diseases has two main components: a subjective one (self-assessment provided by the patient), based mainly on the PROMs (Patient-Reported Outcome Measures) questionnaire, and an objective one (formulated by the clinician). Questionnaires present accuracy and response rate problems that have been investigated in the literature, finding that short questionnaires, incentives, personalization of questionnaires as well as repeat sending strategies or telephone reminders have a beneficial impact on the quantity and quality of responses. Today there are many new channels provided by technology. Among them, AI chatbots have been used in a variety of healthcare domains such as medical consultations, disease diagnosis, mental health support and, more recently, risk communications for the COVID-19 pandemic, and can offer a better way to collect questionnaires. At the same time, the recent technical solution of new non-invasive techniques for RFID radio frequency identification devices allows subjective reports to be accompanied with objective reports. The PRECISION project aims to evaluate systems for home monitoring of chronic rhinosinusitis (CRS) and asthma, two highly prevalent chronic diseases. The frequent association between the two pathological conditions is a further argument in support of the rationality of a common approach. As regards the collection of PROMs, three acquisition channels will be compared: i) AI Chatbots; ii) PhoneBot; iii) Mobile application. Data will be analyzed in relation to patient profiles to define the quality and quality of response. Regarding objective evaluation, the project will investigate the efficiency of objective remote airflow measurements for both upper (CRS) and lower (asthma) airways using dedicated non-invasive systems based on RFID technology.

NCT ID: NCT06217133 Not yet recruiting - Clinical trials for Autonomic Nervous System Imbalance

Heart Rate Variability of Premature Newborn

HRV
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

To analyze the effects of two CPAP methods on the HRV of PTNBs during their routine routine in the HCUFU neonatal ICU. This is a randomized clinical trial, with controlled groups and cross over with healthy term newborns (RNT) as a control group admitted to the HC-UFU rooming-in and premature newborns (PTRN), between 28 and 32 weeks pregnant women with nasal CPAP group admitted to the neonatal ICU of the same hospital. The HRV recorded by the POLAR® RS800cx cardiac monitor will be analyzed, with a sampling rate of 1000 Hz. The main question[s] it aims to answer are: - Is there a difference in heart rate variability between newborns using conventional nasal CPAP and nasal bubble CPAP? - Is it possible to conclude that one of the methods has a greater sympathetic or parasympathetic tone compared to the other? Premature participants will be in the incubators in a supine position with 30 minutes rest after the last handling. Each data collection will last 60 minutes and will be carried out three times a day in the morning, afternoon and night shifts, for each 1-hour collection, HRV will be analyzed in 12 5-minute intervals, establishing an average for each variable of the data. HRV during a 1-hour period. The researchers will compare the conventional CPAP and bubble CPAP group according to randomization. - In the control group, data collection will be carried out in the Rooming Room in a single reference collection lasting 20 minutes, and analyzed in 4 5-minute intervals. - The participant selected for conventional CPAP will receive conventional CPAP for 24 hours, then receive bubble CPAP for 24 hours the following day. The opposite will be done for the participant drawn for CPAP bubbles. The comparison between the conventional CPAP and bubble CPAP groups will occur to find out whether it is possible to identify the type of non-invasive ventilation that allows an increase in HRV and parasympathetic tone variables, as well as a reduction in sympathetic tone variables and the stress index of premature babies.